Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT vs ROSUVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROLAPITANT vs ROSUVASTATIN: Safety Overview

Metric ROLAPITANT ROSUVASTATIN
Total FAERS Reports 873 36,332
Deaths Reported 252 1,536
Death Rate 28.9% 4.2%
Hospitalizations 155 11,195
Average Patient Age 61.4 yrs 66.1 yrs
% Female Patients 57.5% 54.9%
FDA Approval Date Oct 25, 2017 Apr 1, 2020
Manufacturer TerSera Therapeutics LLC Umedica Laboratories USA Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription